Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-006520
Filing Date
2013-02-04
Accepted
2013-02-04 19:12:29
Documents
2
Period of Report
2013-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd368554.html 4  
1 FORM 4 rrd368554.xml 4 3787
2 POWER OF ATTORNEY rrd330997_374235.htm EX-24.1 3982
  Complete submission text file 0001181431-13-006520.txt   9142
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Issuer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Smith Brigitte (Reporting) CIK: 0001555775 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 13571605